For instance, Lcn-2-deficient J20 mice (J20 x Lcn-2 knock-out) showed no improvement in cognitive functions, plaque load or glial activation [28], implying that simply inhibiting Lcn-2 is not enough to attenuate AD-related pathology in this mousemodel. The gene discussed is LCN2; the disease is Alzheimer disease.